| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 116,095 | 109,977 | 106,487 | 102,265 |
| Cost of product revenue | 46,764 | 43,003 | 38,452 | 36,569 |
| Cost of collaboration revenue | 119 | 217 | 195 | 348 |
| Research and development | 47,928 | 50,614 | 60,729 | 65,982 |
| Selling, general, and administrative | 70,106 | 71,038 | 63,422 | 67,219 |
| Loss from operations | -48,822 | -54,895 | -56,311 | -67,853 |
| Interest income | 8,345 | 8,843 | 8,606 | 9,029 |
| Interest expenses | 1,400 | 1,262 | 1,187 | 745 |
| Foreign currency gains | 6,422 | 2,837 | 651 | 14,457 |
| Other income (expense), net | -508 | 3,750 | -197 | 3,441 |
| Loss before income tax | -35,963 | -40,727 | -48,438 | -41,671 |
| Income tax expense | 0 | 0 | - | - |
| Net loss | -35,963 | -40,727 | -48,438 | -41,671 |
| Loss per share - basic (in dollars per share) | -0.03 | -0.04 | -0.04 | -0.04 |
| Loss per share - diluted (in dollars per share) | -0.03 | -0.04 | -0.04 | -0.04 |
| Weighted-average shares used in calculating net loss per ordinary share - basic (in shares) | 1,102,072,680 | 1,091,933,150 | 1,080,825,300 | 981,687,390 |
| Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares) | 1,102,072,680 | 1,091,933,150 | 1,080,825,300 | 981,687,390 |
Zai Lab Ltd (ZLAB)
Zai Lab Ltd (ZLAB)